WB2454 Evolving Medication Use in Neonates Course
WB2454 Evolving Medication Use in Neonates Course is organized by National Certification Corporation (NCC).
Expiration: 12/31/2024
Content Outline:
• Moving from Immature Pharmacology to Pharmacology of the Immature
• Descriptive Analysis Comparing 11 Neonatal Seizure Treatment Pathways
Objectives:
• Review the developmental changes in extremely preterm infants that affect pharmacokinetics (PK) and pharmacodynamics (PD) with impact on drug safety
• Contrast drug utilization patterns observed in extremely low birth weight (ELBW) infants and those at gestational ages of 22-24 weeks with those in the more developmentally mature neonatal population to better reflect needs and practices
• Identify the areas of consensus and the points of variability described for evaluation, confirmation, and the treatment of neonatal seizures as presented in the analysis of eleven management pathways
• List the anti-seizure medication (ASM) options included in the neonatal seizure management pathways and compare the variations in drug selection and dosing between the pathways
• Based on the cohort study as presented, outline the trends in prescribing patterns occurring in the NICU setting from 2010 to 2018 and discuss potential contributing factors leading to increased and decreased utilization of specific medications
